Drug intelligence / Profile preview

Bigflam Fast Tab

Development stage
Unknown
Lead developer
Ultrachem Pharmaceuticals
Modality
Recombinant Proteins and Enzymes, Small Molecules
Administration
Oral
01

Overview

Bigflam Fast Tab is an oral fixed-dose combination therapy developed by Ultrachem Pharmaceuticals for the management of pain, swelling, and inflammation associated with various musculoskeletal and joint disorders, such as osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis, as well as post-surgical and post-traumatic wound healing. The formulation combines the non-steroidal anti-inflammatory drug (NSAID) diclofenac sodium with the bioflavonoid rutoside trihydrate and the proteolytic enzymes trypsin and bromelain. Diclofenac sodium provides rapid analgesic and anti-inflammatory effects by inhibiting cyclooxygenase (COX) enzymes and reducing prostaglandin synthesis. Trypsin and bromelain act as anti-inflammatory and anti-edematous proteases that break down inflammatory proteins, clear fibrin clots, and improve local microcirculation. Rutoside trihydrate acts as an antioxidant and vasoprotective agent that strengthens blood vessels and reduces capillary permeability, thereby accelerating tissue repair and reducing edema.

Brand names
Bigflam Fast TabBigflam Fast Tablet
Other names
bromelain + diclofenac + rutoside + trypsinbromelain + diclofenac sodium + rutoside trihydrate + trypsintrypsin + bromelain + rutoside + diclofenactrypsin + bromelain + rutoside trihydrate + diclofenac sodium
02

Targets

PTGS2 (Prostaglandin-Endoperoxide Synthase 2)Fibrin (Factor Ia)PGHS-1 (Prostaglandin G/H Synthase 1)

Beyond the preview

Go deeper on Bigflam Fast Tab.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bigflam Fast Tab.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call